Exploring the Utility of [18F]3F4AP for Demyelination Imaging
Yale University · with National Institute for Biomedical Imaging and Bioengineering (NIBIB), National Institute on Aging (NIA) · NCT06999434
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–90 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 1
- Target enrollment
- 105
- US sites recruiting
- 1
- Study start
- May 5, 2025
- Record last updated
- September 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The overall objective is to obtain an assessment of the pharmacokinetics of [18F]3F4AP in healthy volunteers and subjects with demyelinating diseases such as mild cognitive impairment (MCI), Alzheimer's Disease (AD), Multiple Sclerosis (MS), Spinal Cord Injury (SCI) and Spinal radiculopathy (SR).
Being studied: [ 18F]3F4AP; [18F]MK6240; [11C]PIB
Conditions: Demyelinating Disorders; MCI; Alzheimer's Disease (AD); MS (Multiple Sclerosis); SCI - Spinal Cord Injury; Spinal Radiculopathy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion
- Male and Female subjects must be ≥18 and \<90 years of age;
- Able to understand and provide informed consent prior to study procedures
- Must be in good health
Exclusion
- Less than 18 years of age;
- Pregnant or breastfeeding;
- Any significant systemic illness or unstable medical condition;
- Pre-existing medical conditions or claustrophobic reactions;
- Research-related radiation exposure exceeds current PET Center guidelines (i.e. 50 mSv in the prior 12 months);
- History of a bleeding disorder or are currently taking anticoagulants.
Recruiting US locations
Yale University PET Center
New Haven, CT 06510
Study contacts (from the official record)
- Shannan Henry · +1 (203) 737-5278 · shannan.henry@yale.edu
- Kayla Cottiers · 203-737-7496 · kayla.cottiers@yale.edu
Similar studies in Connecticut
All neurology studies in Connecticut →- RecruitingHealthy volunteersPhase 1
MK-0947 PN-002: An Open-label Study to Evaluate Brain α-synuclein Deposition Using Positron Emission Tomography (PET) and [¹⁸F]MK-0947 in Participants With Parkinson's Disease (PD)
XingImaging, LLC
- Location
- New Haven, CT
- Eligibility basics
- Ages 40–80
- RecruitingHealthy volunteersEarly Phase 1
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
MODAG GmbH
- Location
- New Haven, CT
- Eligibility basics
- Ages 50–80
- RecruitingHealthy volunteersEarly Phase 1
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
MODAG GmbH
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–60
- RecruitingHealthy volunteersPhase 1/Phase 2
SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral Therapy
Yale University
- Location
- New Haven, CT
- Eligibility basics
- Ages 18–80